Eiko Lifesciences Ltd (EIKO) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Eiko Lifesciences Ltd reported sales of ₹16.75 Cr, operating profit of ₹1.93 Cr (OPM 11.52%) and net profit of ₹1.51 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
EIKO quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 8.16 7.49 11.27 10.71 11.67 11.98 18.34 16.75 Expenses 7.73 6.86 9.95 9.2 9.9 10.1 16.08 14.82 Operating Profit 0.43 0.63 1.32 1.51 1.77 1.88 2.26 1.93 OPM 5.27% 8.41% 11.71% 14.1% 15.17% 15.69% 12.32% 11.52% Other Income 0.13 0.12 0.64 0.27 0.3 0.35 0.13 0.45 Interest 0.04 0.03 0.07 0.05 0.1 0.07 0.12 0.13 Depreciation 0.16 0.16 0.25 0.25 0.26 0.26 0.25 0.25 Profit before tax 0.36 0.56 1.64 1.48 1.71 1.9 2.02 2 Tax 27.78% 25% 23.78% 25% 24.56% 24.74% 25.74% 24.5% Net Profit 0.28 0.42 1.25 1.11 1.29 1.43 1.5 1.51 EPS in Rs 0.22 0.33 0.84 0.66 0.79 0.88 0.91 0.91
EIKO profit & loss, annual (₹ Cr) Metric Mar 2018 Mar 2019 Mar 2020 Mar 2025 Mar 2026 TTM Sales 2.36 4.27 10.4 37.66 52.71 58.74 Expenses 1.98 4.95 14.91 34.89 45.28 50.9 Operating Profit 0.38 -0.68 -4.51 2.77 7.43 7.84 OPM 16.1% -15.93% -43.37% 7.36% 14.1% 13.35% Other Income 0.04 0.04 0.01 1.2 1.03 1.23 Interest 0.09 0.19 0.24 0.17 0.33 0.42 Depreciation 0.08 0.17 0.19 0.74 1.02 1.02 Profit before tax 0.25 -1 -4.93 3.06 7.11 7.63 Tax 20% -21% -26.77% 24.51% 25.18% - Net Profit 0.2 -0.78 -3.62 2.32 5.33 5.73 EPS in Rs 0.31 -0.69 -2.98 1.86 3.14 3.49 Dividend Payout 0% 0% 0% 0% 0% -
EIKO balance sheet (₹ Cr) Metric Mar 2018 Mar 2019 Mar 2020 Mar 2025 Mar 2026 Equity Capital 3.82 3.82 3.82 13.76 14.35 Reserves 1.74 1.1 -0.87 43.03 54.43 Borrowings 1.74 1.37 1.61 2.76 4.73 Other Liabilities 3.66 3.01 7.49 6.56 15.86 Total Liabilities 10.96 9.3 12.05 66.11 89.37 Fixed Assets 1.68 1.71 1.75 23.12 22.1 CWIP 0 0 0 0 0 Investments 3.17 1.72 0.1 7.15 15.29 Other Assets 6.11 5.87 10.2 35.84 51.98 Total Assets 10.96 9.3 12.05 66.11 89.37
EIKO cash flows (₹ Cr) Metric Mar 2019 Mar 2020 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 0.16 -0.33 - 2.92 2.28 Cash from Investing Activity -0.3 -0.71 - -11.44 -8.66 Cash from Financing Activity -0.55 0.95 - 6.96 8.21 Net Cash Flow -0.69 -0.09 - -1.57 1.83 Free Cash Flow -0.04 -0.56 - -7.37 2.28 CFO/OP -26% 7% - 117% 50%
EIKO ratios Metric Mar 2018 Mar 2019 Mar 2020 Mar 2025 Mar 2026 Debtor Days 225.81 73.51 41.41 104.58 140.02 Inventory Days 819.93 287.76 153.96 64.48 35.09 Days Payable 605.69 174.4 184.66 36.99 111.03 Cash Conversion Cycle 440.04 186.87 10.72 132.07 64.08 Working Capital Days 80.42 -1.71 -151.62 143.73 127.55 ROCE - -11.83% -105.39% - 11.08%